These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23601299)

  • 1. [Tumor-stroma ratio is an independent prognostic factor of non-small cell lung cancer].
    Wang Z; Liu H; Zhao R; Zhang H; Liu C; Song Y
    Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):191-6. PubMed ID: 23601299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-stroma ratio is an independent predictor for survival in NSCLC.
    Zhang T; Xu J; Shen H; Dong W; Ni Y; Du J
    Int J Clin Exp Pathol; 2015; 8(9):11348-55. PubMed ID: 26617859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival.
    Xi KX; Wen YS; Zhu CM; Yu XY; Qin RQ; Zhang XW; Lin YB; Rong TH; Wang WD; Chen YQ; Zhang LJ
    J Thorac Dis; 2017 Oct; 9(10):4017-4026. PubMed ID: 29268412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
    Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
    Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.
    Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y
    J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study.
    Smit MA; Philipsen MW; Postmus PE; Putter H; Tollenaar RA; Cohen D; Mesker WE
    Cancer Treat Res Commun; 2020; 25():100247. PubMed ID: 33249210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
    Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
    Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Role of Tumor-Stroma Ratio for Survival of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis.
    Zhang X; Ma H; Zhang L; Li F
    Pathol Oncol Res; 2021; 27():1610021. PubMed ID: 35132307
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
    Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
    Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
    Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
    World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
    Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
    Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
    Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer.
    Geessink OGF; Baidoshvili A; Klaase JM; Ehteshami Bejnordi B; Litjens GJS; van Pelt GW; Mesker WE; Nagtegaal ID; Ciompi F; van der Laak JAWM
    Cell Oncol (Dordr); 2019 Jun; 42(3):331-341. PubMed ID: 30825182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.
    Qian L; Ji AH; Zhang WJ; Zhao N
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):430-442. PubMed ID: 29424924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
    Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
    Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.